A carregar...

In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats

We recently described a mAb 3.2.3 (IgG1), that recognizes a 60-kD dimeric molecule expressed exclusively on fresh and rIL-2-activated NK cells and polymorphonuclear cells. mAb 3.2.3 enhances cytolytic activity of NK cells against selected FcR+ tumor target cells by reverse antibody-dependent cellula...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Formato: Artigo
Idioma:Inglês
Publicado em: The Rockefeller University Press 1990
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2187674/
https://ncbi.nlm.nih.gov/pubmed/2295876
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!